Article Versions Notes

Alrasheed MA, Alamer KA, Albishi M, Alsuhibani AA, Almohammed OA, Alwhaibi A, Almajed AN, Guo JJ. Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022. Pharmaceuticals. 2024; 17(7):815. https://doi.org/10.3390/ph17070815

Alrasheed, Marwan A., Khalid A. Alamer, Mashael Albishi, Abdulrahman A. Alsuhibani, Omar A. Almohammed, Abdulrahman Alwhaibi, Abdullah N. Almajed, and Jeff J. Guo. 2024. "Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022" Pharmaceuticals 17, no. 7: 815. https://doi.org/10.3390/ph17070815

Alrasheed, M. A., Alamer, K. A., Albishi, M., Alsuhibani, A. A., Almohammed, O. A., Alwhaibi, A., Almajed, A. N., & Guo, J. J. (2024). Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022. Pharmaceuticals, 17(7), 815. https://doi.org/10.3390/ph17070815